Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: Effect of the proprotein convertase subtilisin/kexin type 9 inhibitor evolocumab on glycemia, body weight, and new-onset diabetes mellitus. Have a read: https://www.m3india.in/contents/journal/effect-of-the-proprotein-convertase-subtilisin?utm_campaign=unset&utm_medium=share&utm_source=ref_wa